This archive report was first published on 8 July 2021.
Published on July 8, 2021, Kenya has returned to the Global Fund for $31.1 million to bolster its Covid-19 response, as part of an ambitious vaccination plan targeting the entire adult population by the end of 2022.
The country aims to vaccinate 26 million adult Kenyans by the end of next year, with the new funding set to support the purchase of vaccines through the African Union facility and Covax, the global scheme for sharing jabs.
According to Health Chief Administrative Secretary Rashid Aman, the country submitted an additional funding request of Ksh3.3 billion ($31.1 million) on June 15, which is currently under review.
Previous Global Fund grants have supported the purchase of automated and manual test kits, personal protective equipment (PPEs), and oxygen equipment, as well as containment activities at the community level.
The Global Fund has so far approved Ksh7.44 billion ($68.9 million) in grants to support Kenya in mitigating the effects of the pandemic under its Covid-19 Response Mechanism (C19RM) programme.
